Related Experiment Videos
CSF 5-hydroxyindoleacetic acid levels in suicidal schizophrenic patients
The American Journal of Psychiatry
|April 1, 1984
Summary
Suicidal schizophrenic patients had lower levels of 5-hydroxyindoleacetic acid (5-HIAA) in cerebrospinal fluid (CSF). This suggests low CSF 5-HIAA may indicate self-directed or other-directed aggressive behavior.
Area of Science:
- Neuroscience
- Psychiatry
- Biochemistry
Background:
- Schizophrenia is a severe mental disorder associated with increased suicide risk.
- Cerebrospinal fluid (CSF) levels of 5-hydroxyindoleacetic acid (5-HIAA), a metabolite of serotonin, have been investigated as potential biomarkers in psychiatric conditions.
- Previous studies suggest a link between low CSF 5-HIAA and suicidal behavior in various psychiatric populations.
Purpose of the Study:
- To investigate the association between CSF 5-HIAA concentrations and suicidal behavior in patients with schizophrenia.
- To determine if low CSF 5-HIAA levels are specific to suicidal behavior in schizophrenia or a more generalized marker.
Main Methods:
- Lumbar cerebrospinal fluid (CSF) was collected from two groups of patients diagnosed with schizophrenia.
- One group comprised patients with a history of suicidal behavior, while the other group consisted of matched nonsuicidal patients.
- Concentrations of 5-hydroxyindoleacetic acid (5-HIAA) were quantified in the CSF samples from all participants.
Main Results:
- Patients in the suicidal schizophrenic group exhibited significantly lower concentrations of 5-hydroxyindoleacetic acid (5-HIAA) in their lumbar CSF compared to the nonsuicidal group.
- The observed reduction in CSF 5-HIAA levels in suicidal schizophrenic patients aligns with findings in other psychiatric disorders.
Conclusions:
- Low levels of cerebrospinal fluid (CSF) 5-hydroxyindoleacetic acid (5-HIAA) may serve as a generalized neurochemical marker associated with aggressive behavior, encompassing both self-directed (suicidal) and other-directed actions.
- This finding supports the role of serotonergic system dysfunction in the pathophysiology of suicidal behavior across different psychiatric diagnoses.
- Further research is warranted to explore the clinical utility of CSF 5-HIAA as a biomarker for suicide risk assessment in schizophrenia and other mental health conditions.